Empire Discovery Institute Seeks CEO
Tuesday, October 16, 2018
Source: Empire Discovery Institute
The Empire Discovery Institute represents a $47 million partnership between the University of Rochester, the University at Buffalo, and the Roswell Park Cancer Institute that advances drug discovery in Upstate New York. An independent, not-for-profit entity, EDI provides the infrastructure for rapid identification and development of the most promising biomedical research emerging from each institution. EDI’s focus will be on early-stage drug discovery including therapeutic efficacy and safety in animal models and in vivo “proof-of-concept” clinical trial validation. To accomplish this, EDI will draw on and leverage unique university resources of its member institutions and within New York State. By moving new drug candidates through the discovery and validation stages more efficiently, EDI improves the efficiency of early stage discovery research and compliments this portfolio with the tools, industry expertise, project management acumen, and external funding required to convert the highest potential targets into de-risked commercial opportunities and life-saving medicines. EDI will provide a life-changing pipeline of treatments to patients across the world, fuel on-going scientific innovations, and generate measurable economic growth for New York State.
EDI is seeking a highly enthusiastic, entrepreneurial leader to build a new drug discovery company unrivaled within New York State. As CEO, this visionary candidate will work with the EDI Board, its partner institutions, NYS health care companies, venture capital firms, NewYorkBIO, MedTech, and the Tri-Institutional Therapeutics Discovery Institution (Tri-TDI) to transform New York State into an unparalleled life science hub. This unified hub will advance life-saving science to patients and serve as a catalyst for new jobs, new companies and new industry-academic drug discovery collaboration opportunities in Upstate New York and throughout the state.